![TILT Biotherapeutics Oy](https://tesi.fi/wp-content/uploads/2022/06/TILT-1-200x113.png)
Portfolio
Venture Capital
Venture Capital
Industry
Healthcare and life sciences
Healthcare and life sciences
Manager
Miia Kaye
Miia Kaye
Investment Year
2022
2022
TILT Biotherapeutics is a biotechnology company that develops cancer immunotherapies, or, trying to harness body’s own immune system against the cancer cells.